Why the study?
Risk assessment for carotid atherosclerotic lesions involves plaque morphology and composition beyond stenosis degree, prompting evaluation of carotid contrast-enhanced ultrasound utility.
Does contrast-enhanced ultrasound (CEUS) accurately assess carotid plaque vulnerability in patients with carotid atherosclerotic lesions?
Does contrast-enhanced ultrasound (CEUS) accurately assess carotid plaque vulnerability in patients with carotid atherosclerotic lesions?
Contrast-enhanced ultrasound is a promising imaging modality for assessing carotid plaque vulnerability and intraplaque neovascularization, though further prospective studies are required to link these findings to clinical outcomes.
CEUS may aid noninvasive carotid plaque vulnerability assessment; hypothesis-generating and requires prospective validation before practice change.
The risk assessment for carotid atherosclerotic lesions involves not only determining the degree of stenosis but also plaque morphology and its composition. Recently, carotid contrast-enhanced ultrasound (CEUS) has gained importance for evaluating vulnerable plaques. This review explores CEUS's utility in detecting carotid plaque surface irregularities and ulcerations as well as intraplaque neovascularization and its alignment with histology. Initial indications suggest that CEUS might have the potential to anticipate cerebrovascular incidents. Nevertheless, there is a need for extensive, multicenter prospective studies that explore the relationships between CEUS observations and patient clinical outcomes in cases of carotid atherosclerotic disease.
No takes yet. Share an insight, caveat, or question.
Kopyto et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: